Characterization of epithelial chemoattractants for human intestinal intraepithelial lymphocytes

Gastroenterology. 2001 Jan;120(1):60-70. doi: 10.1053/gast.2001.20904.

Abstract

Background & aims: Although homing of intraepithelial lymphocytes (IEL) into intestinal epithelia seems to be guided by signals from epithelia, little is known concerning functional epithelial-derived chemoattractants for IEL.

Methods: Epithelial chemoattractants for IEL were analyzed using chemotaxis chamber system, enzyme-linked immunosorbent assay, and in situ hybridization using human epithelial lines and IEL lines.

Results: Epithelial-conditioned media induced IEL chemotaxis, and this activity was markedly enhanced by prestimulation of epithelia with interferon-(IFN)-gamma. This chemotaxis (stimulation +) was significantly inhibited by neutralizing antibodies to IFN-gamma inducible protein-10 (IP-10) or to monokine induced by IFN-gamma (MIG). Furthermore, while high amounts of IP-10 and MIG were detected in epithelial-conditioned media after IFN-gamma stimulation, equivalent concentrations of recombinant IP-10 and MIG reproduced IEL chemotaxis. Production of IP-10 and MIG in fresh epithelial cells was supported by in situ hybridization and enzyme-linked immunosorbent assay. Lastly, fresh human IEL constitutively expressed CXCR-3 (the common receptor for IP-10 and MIG), and fresh IEL also exhibited chemotaxis to by rIP-10, rMIG, and epithelial-conditioned media.

Conclusions: Epithelial cells produce chemoattractants for IEL, and such chemokine production is regulated by proinflammatory cytokines such as IFN-gamma. IP-10 and MIG may serve as potentially important epithelial chemokines for IEL, especially under inflammatory conditions.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies / pharmacology
  • Antineoplastic Agents / pharmacology
  • Cells, Cultured
  • Chemokine CXCL10
  • Chemokine CXCL9
  • Chemokines, CXC / immunology
  • Chemokines, CXC / metabolism*
  • Chemotaxis, Leukocyte / drug effects
  • Chemotaxis, Leukocyte / physiology*
  • Colitis / immunology
  • Colitis / metabolism
  • Colon / cytology
  • Colon / immunology
  • Colon / metabolism
  • Gene Expression / physiology
  • HT29 Cells
  • Humans
  • Intercellular Signaling Peptides and Proteins*
  • Interferon-gamma / pharmacology
  • Interleukin-1 / pharmacology
  • Intestinal Mucosa / cytology
  • Intestinal Mucosa / immunology*
  • Intestinal Mucosa / metabolism*
  • Lymphocytes / cytology*
  • RNA, Messenger / analysis
  • Receptors, CXCR3
  • Receptors, Chemokine / genetics
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Antibodies
  • Antineoplastic Agents
  • CXCL9 protein, human
  • CXCR3 protein, human
  • Chemokine CXCL10
  • Chemokine CXCL9
  • Chemokines, CXC
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-1
  • RNA, Messenger
  • Receptors, CXCR3
  • Receptors, Chemokine
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma